CervoMed Inc. Earnings Per Share (Basic)
CervoMed Inc. (CRVO) reported Earnings Per Share (Basic) of -$0.64 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-07
- CervoMed Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.64.
- CervoMed Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.86.
- CervoMed Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.84.
- CervoMed Inc. earnings per share, basic for the quarter ending 2025-06-30 was -$0.70.
- CervoMed Inc. earnings per share, basic for fiscal 2025 was -$2.98.
- CervoMed Inc. earnings per share, basic for fiscal 2024 was -$2.02.
- CervoMed Inc. earnings per share, basic for fiscal 2023 was -$0.82.
- CervoMed Inc. earnings per share, basic for fiscal 2022 was -$11.20.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.64 10-Q · filed 2026-08-07 | -$1.49 10-Q · filed 2026-08-07 | ||||||
| 2026-03-31 | -$0.86 10-Q · filed 2026-05-15 | |||||||
| 2025-12-31 | -$2.98 10-K · filed 2026-03-13 | |||||||
| 2025-09-30 | -$0.84 10-Q · filed 2025-11-07 | -$2.10 10-Q · filed 2025-11-07 | ||||||
| 2025-06-30 | -$0.70 10-Q · filed 2026-08-07 | -$1.26 10-Q · filed 2026-08-07 | ||||||
| 2025-03-31 | -$0.56 10-Q · filed 2026-05-15 | |||||||
| 2024-12-31 | -$2.02 10-K · filed 2026-03-13 | |||||||
| 2024-09-30 | -$0.55 10-Q · filed 2025-11-07 | -$1.22 10-Q · filed 2025-11-07 | ||||||
| 2024-06-30 | -$0.27 10-Q · filed 2025-08-08 | -$0.65 10-Q · filed 2025-08-08 | ||||||
| 2024-03-31 | -$0.41 10-Q · filed 2025-05-12 | |||||||
| 2023-12-31 | -$0.82 10-K · filed 2025-03-17 | |||||||
| 2023-09-30 | $0.65 10-Q · filed 2024-11-12 | $0.13 10-Q · filed 2024-11-12 | ||||||
| 2023-06-30 | -$2.75 10-Q · filed 2024-08-09 | -$1.04 10-Q · filed 2023-08-08 | -$3.78 10-Q · filed 2024-08-09 | -$3.04 10-Q · filed 2023-08-08 | ||||
| 2023-03-31 | -$1.03 10-Q · filed 2024-05-14 | -$1.95 10-Q · filed 2023-05-15 | ||||||
| 2022-12-31 | -$11.20 10-K · filed 2024-03-29 | -$7.65 10-K · filed 2023-03-24 | ||||||
| 2022-09-30 | -$1.70 10-Q · filed 2023-11-13 | -$1.37 10-Q · filed 2022-11-14 | -$8.25 10-Q · filed 2023-11-13 | -$5.65 10-Q · filed 2022-11-14 | ||||
| 2022-06-30 | -$2.06 10-Q · filed 2023-08-08 | -$4.28 10-Q · filed 2023-08-08 | ||||||
| 2022-03-31 | -$2.22 10-Q · filed 2023-05-15 | |||||||
| 2021-12-31 | -$12.38 10-K · filed 2023-03-24 | -$0.25 10-K · filed 2022-03-18 | ||||||
| 2021-09-30 | -$5.99 10-Q · filed 2022-11-14 | -$0.12 10-Q · filed 2021-11-10 | -$7.84 derived: net income ÷ weighted average shares · filed 2022-11-14 | -$10.76 10-Q · filed 2022-11-14 | -$0.22 10-Q · filed 2021-11-10 | |||
| 2021-06-30 | -$1.85 10-Q · filed 2022-08-12 | -$0.04 10-Q · filed 2021-08-11 | -$4.54 10-Q · filed 2022-08-12 | -$0.09 10-Q · filed 2021-08-11 | ||||
| 2021-03-31 | -$2.81 10-Q · filed 2022-05-12 | -$0.06 10-Q · filed 2021-05-07 | ||||||
| 2020-12-31 | -$0.30 10-K · filed 2022-03-18 | |||||||
| 2020-09-30 | -$0.07 10-Q · filed 2021-11-10 | -$0.24 10-Q · filed 2021-11-10 | ||||||
| 2020-06-30 | -$0.10 10-Q · filed 2021-08-11 | -$0.18 10-Q · filed 2021-08-11 | ||||||
| 2020-03-31 | -$0.07 10-Q · filed 2021-05-07 | |||||||
| 2019-12-31 | -$1.76 10-K · filed 2021-03-17 | |||||||
| 2019-09-30 | -$0.60 10-Q · filed 2020-11-12 | -$2.01 10-Q · filed 2020-11-12 | ||||||
| 2019-06-30 | -$0.63 10-Q · filed 2020-08-07 | -$1.43 10-Q · filed 2020-08-07 | ||||||
| 2019-03-31 | -$0.81 10-Q · filed 2020-05-11 | |||||||
| 2018-12-31 | $0.04 derived: net income ÷ weighted average shares · filed 2020-03-17 | $0.31 derived: net income ÷ weighted average shares · filed 2020-03-17 | $1.54 derived: net income ÷ weighted average shares · filed 2020-03-17 | -$8.21 10-K · filed 2020-03-17 | ||||
| 2018-09-30 | -$1.99 10-Q · filed 2019-11-08 | -$0.13 10-Q · filed 2018-11-13 | -$0.19 derived: net income ÷ weighted average shares · filed 2019-11-08 | -$6.61 10-Q · filed 2019-11-08 | -$0.44 10-Q · filed 2018-11-13 | |||
| 2018-06-30 | -$0.82 10-Q · filed 2019-08-08 | -$0.05 10-Q · filed 2018-08-10 | -$4.64 10-Q · filed 2019-08-08 | -$0.31 10-Q · filed 2018-08-10 | ||||
| 2018-03-31 | -$4.11 10-Q · filed 2019-05-09 | |||||||
| 2017-12-31 | -$0.05 derived: net income ÷ weighted average shares · filed 2019-03-19 | -$0.49 derived: net income ÷ weighted average shares · filed 2019-03-19 | -$10.31 derived: net income ÷ weighted average shares · filed 2019-03-19 | -$3.16 10-K · filed 2019-03-19 | -$0.21 10-K · filed 2018-04-02 | |||
| 2017-09-30 | $0.21 10-Q · filed 2018-11-13 | $1.84 derived: net income ÷ weighted average shares · filed 2018-11-13 | -$0.35 10-Q · filed 2018-11-13 | |||||
| 2017-06-30 | $0.88 10-Q · filed 2018-08-10 | -$0.83 10-Q · filed 2018-08-10 | ||||||
| 2016-12-31 | -$0.25 derived: net income ÷ weighted average shares · filed 2018-04-02 | -$0.77 derived: net income ÷ weighted average shares · filed 2018-04-02 | -$1.15 derived: net income ÷ weighted average shares · filed 2018-04-02 | -$1.76 10-K · filed 2018-04-02 | ||||
| 2016-09-30 | -$0.53 10-Q · filed 2017-11-13 | -$0.90 derived: net income ÷ weighted average shares · filed 2017-11-13 | -$1.52 10-Q · filed 2017-11-13 | |||||
| 2016-06-30 | -$0.37 10-Q · filed 2017-08-14 | -$0.99 10-Q · filed 2017-08-14 | ||||||
| 2015-12-31 | -$1.06 derived: net income ÷ weighted average shares · filed 2016-03-25 | -$1.78 derived: net income ÷ weighted average shares · filed 2016-03-25 | -$1.99 derived: net income ÷ weighted average shares · filed 2016-03-25 | -$1.28 derived: net income ÷ weighted average shares · filed 2016-03-25 | ||||
| 2015-09-30 | -$0.71 derived: net income ÷ weighted average shares · filed 2015-11-12 | -$0.92 derived: net income ÷ weighted average shares · filed 2015-11-12 | -$0.21 derived: net income ÷ weighted average shares · filed 2016-11-14 | -$1.23 derived: net income ÷ weighted average shares · filed 2016-05-16 | ||||
| 2015-06-30 | -$0.21 derived: net income ÷ weighted average shares · filed 2015-08-12 | -$0.14 derived: net income ÷ weighted average shares · filed 2016-08-15 | -$0.53 derived: net income ÷ weighted average shares · filed 2016-05-16 | -$0.72 derived: net income ÷ weighted average shares · filed 2016-05-16 | ||||
| 2015-03-31 | -$0.07 derived: net income ÷ weighted average shares · filed 2016-05-16 | -$0.32 derived: net income ÷ weighted average shares · filed 2016-05-16 | -$0.50 derived: net income ÷ weighted average shares · filed 2016-05-16 | -$0.80 derived: net income ÷ weighted average shares · filed 2016-05-16 | ||||
| 2014-12-31 | -$0.24 derived: net income ÷ weighted average shares · filed 2016-03-25 | -$0.43 derived: net income ÷ weighted average shares · filed 2016-03-25 | -$0.74 derived: net income ÷ weighted average shares · filed 2016-03-25 | -$1.00 derived: net income ÷ weighted average shares · filed 2016-03-25 | ||||
| 2014-09-30 | -$0.18 derived: net income ÷ weighted average shares · filed 2015-11-12 | -$0.50 derived: net income ÷ weighted average shares · filed 2015-11-12 | -$0.76 derived: net income ÷ weighted average shares · filed 2015-11-12 | |||||
| 2014-06-30 | -$0.35 derived: net income ÷ weighted average shares · filed 2015-08-12 | -$0.62 derived: net income ÷ weighted average shares · filed 2015-08-12 | ||||||
| 2014-03-31 | -$0.23 derived: net income ÷ weighted average shares · filed 2015-05-11 | |||||||
| 2012-09-30 | -$0.02 derived: net income ÷ weighted average shares · filed 2013-11-19 | -$0.03 derived: net income ÷ weighted average shares · filed 2013-11-19 | -$0.26 derived: net income ÷ weighted average shares · filed 2013-11-19 | |||||
| 2012-06-30 | -$0.02 derived: net income ÷ weighted average shares · filed 2013-11-19 | -$0.24 derived: net income ÷ weighted average shares · filed 2013-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |